\-\ Texto\\:\\ \ \(0\)\
\-\ vitals\\:\\ bp\\ 98\\/59\\,\\ pulse\\ 104\\,\\ temp\\ 36\\.8c\\,\\ resp\\ rate\\ 28\\,\\ height\\ 105cm\\,\\ weight\\ 17kg\ \(0\)\
\-\ general\\:\\ awake\\,\\ alert\\,\\ cooperative\\ with\\ exam\\,\\ no\\ acute\\ distress\ \(0\)\
\-\ head\\:\\ diffuse\\ seborrheic\\ dermatitis\\,\\ 3\\.5x4cm\\ scabbed\\ lesion\\ on\\ l\\ frontal\\ scalp\ \(0\)\
\-\ ears\\:\\ tympanic\\ membranes\\ obstructed\\ bilaterally\\ by\\ purulent\\ fluid\\ in\\ external\\ canals\ \(0\)\
\-\ abdomen\\:\\ distended\\,\\ hepatomegaly\\,\\ hyperactive\\ bowel\\ sounds\ \(0\)\
\-\ neuro\\:\\ no\\ focal\\ deficits\\,\\ cn\\ 2\\-12\\ grossly\\ intact\\,\\ reflexes\\ 2\\+\\ bilaterally\ \(0\)\
\-\ remainder\\ of\\ physical\\ exam\\ reassuring\\ and\\ without\\ abnormalities\ \(0\)\
\-\ bmp\\:\\ na\\ 143\\|k\\ 3\\.3\\|cl\\ 109\\|co2\\ 25\\|bun\\ 5\\|cr\\ 0\\.3\\|glu\\ 80\ \(0\)\
\-\ serum\\ osmolality\\:\\ 286\ \(0\)\
\-\ urine\\ sodium\\:\\ 11\ \(0\)\
\-\ urine\\ osmolality\\:\\ 41\ \(0\)\
\-\ concurrent\\ diabetes\\ insipidus\\ treated\\ with\\ vasopressin\\ and\\ followed\\ by\\ endocrinology\ \(0\)\
\-\ vinblastine\\,\\ prednisone\\ managed\\ by\\ hematology\\/oncology\ \(0\)\
\-\ close\\ follow\\-up\\ with\\ neurosurgery\\ given\\ location\\ of\\ lesion\ \(0\)\
\-\ xr\\ skull\\:\\ \\‚\\Ä\\úpunched\\ out\\‚\\Ä\\ù\\ lytic\\ lesions\\ involving\\ left\\ parietal\\ and\\ temporal\\ bones\ \(0\)\
\-\ ct\\ head\\:\\ large\\ lytic\\ lesion\\ involving\\ left\\ parietal\\,\\ temporal\\,\\ occipital\\,\\ and\\ greater\\ wing\\ of\\ sphenoid\\ bone\\.\\ significant\\ bony\\ destruction\\ involving\\ temporal\\ bone\\ with\\ soft\\ tissue\\ extension\\ into\\ the\\ external\\ auditory\\ canal\\,\\ middle\\ ear\\ cavity\\,\\ left\\ parapharyngeal\\ fat\\,\\ and\\ lateral\\ pterygoid\\ and\\ temporalis\\ musculature\\.\\ second\\ \\(1cm\\)\\ lytic\\ lesion\\ in\\ the\\ right\\ mastoid\\ sinus\\ with\\ erosion\\ of\\ the\\ anterior\\ and\\ inferior\\ wall\\ and\\ extension\\ into\\ the\\ right\\ external\\ auditory\\ canal\\.\\ \ \(0\)\
\-\ mr\\ brain\\:\\ extensive\\ enhancing\\ soft\\ tissue\\ mass\\ with\\ bone\\ destruction\\ throughout\\ left\\ temporal\\ bone\\ with\\ extension\\ to\\ occipital\\ and\\ sphenoid\\ bones\\.\\ additional\\ erosion\\ of\\ left\\ mandibular\\ condyle\\ and\\ right\\ mastoid\\ sinus\\.\\ enhancing\\ mass\\ present\\ at\\ the\\ infundibulum\\.\\ disease\\ extension\\ into\\ the\\ upper\\ neck\\ surrounding\\,\\ but\\ not\\ narrowing\\ the\\ internal\\ carotid\\ artery\\.\\ \ \(0\)\
\-\ us\\ abdomen\\:\\ borderline\\ hepatomegaly\\,\\ no\\ intra\\-abdominal\\ mass\\ identified\\.\\ bilateral\\ extrarenal\\ pelvises\\ without\\ caliectasis\\.\\ kidneys\\ otherwise\\ normal\\ in\\ appearance\\.\\ \ \(0\)\
\-\ xr\\ abdomen\\:\\ prominent\\ hepatic\\ shadow\\.\\ \ \(0\)\
\-\ xr\\ chest\\:\\ no\\ acute\\ pulmonary\\ consolidation\\.\\ \ \(0\)\
\-\ ct\\ chest\\,\\ abdomen\\,\\ pelvis\\:\\ normal\\ study\\.\\ \ \(0\)\
\-\ nuclear\\ bone\\ scan\\:\\ solitary\\ lesion\\ in\\ left\\ temporoparietal\\ cavarium\\.\\ no\\ additional\\ skeletal\\ abnormality\\.\ \(0\)\
\-\ langerhans\\ cell\\ histiocytosis\ \(1\)\
\-\ langerhan\\‚\\Ä\\ôs\\ cell\\ histiocytosis\ \(0\)\
\-\ sarcoidosis\ \(108\)\
\-\ neuroblastoma\ \(81\)\
\-\ osteosarcoma\ \(92\)\
\-\ rhabdomyosarcoma\ \(41\)\
\-\ osteomyelitis\ \(170\)\
\-\ 4\\ year\\ old\\ male\\ with\\ history\\ of\\ non\\-healing\\ lesion\\ on\\ scalp\\ for\\ approximately\\ 12\\ months\\ along\\ with\\ seborrheic\\ changes\\ of\\ scalp\\.\\ lesions\\ were\\ not\\ responsive\\ to\\ griseofulvin\\ or\\ hydrocortisone\\ creams\\.\\ concurrent\\ history\\ of\\ polydipsia\\,\\ polyuria\\,\\ and\\ purulent\\ drainage\\ from\\ bilateral\\ external\\ auditory\\ canals\\.\ \(0\)\
\-\ in\\ this\\ case\\,\\ the\\ patient\\ is\\ near\\ the\\ age\\ range\\ \\(5\\-10\\ years\\ old\\)\\ typically\\ associated\\ with\\ eosinophilic\\ granuloma\\ \\(langerhans\\ cell\\ histiocytosis\\)\\.\\ secondary\\ to\\ intracranial\\ tumor\\ extension\\,\\ this\\ patient\\ was\\ treated\\ for\\ concurrent\\ diabetes\\ insipidus\\ with\\ vasopressin\\.\\ with\\ clinically\\ demonstrated\\ cns\\ involvement\\,\\ there\\ is\\ increased\\ risk\\ for\\ this\\ patient\\ to\\ develop\\ additional\\ cns\\ complications\\.\\ due\\ to\\ temporal\\ bone\\ involvement\\,\\ potential\\ for\\ otitis\\ media\\ refractory\\ to\\ antibiotic\\ treatment\\ and\\ hearing\\ loss\\ in\\ the\\ left\\ ear\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ \\:\\:\\ 0\\.04093550641414884\ \(0\)\
\-\ xr\\:\\ 0\\.03821294833508147\ \(0\)\
\-\ concurrent\\:\\ 0\\.03576547283342254\ \(0\)\
\-\ temporal\\:\\ 0\\.03442546154541385\ \(0\)\
\-\ seborrheic\\:\\ 0\\.032685598565016315\ \(0\)\
\-\ osmolality\\:\\ 0\\.032685598565016315\ \(0\)\
\-\ vasopressin\\:\\ 0\\.032685598565016315\ \(0\)\
\-\ extension\\:\\ 0\\.03068739759740094\ \(0\)\
\-\ auditory\\:\\ 0\\.02936181914719358\ \(0\)\
\-\ external\\:\\ 0\\.029245351095971137\ \(0\)\
\-\ scalp\\:\\ 0\\.02913401032637157\ \(0\)\
\-\ histiocytosis\\:\\ 0\\.02870266849146929\ \(0\)\
\-\ insipidus\\:\\ 0\\.028264623560315668\ \(0\)\
\-\ bone\\:\\ 0\\.02563502633553163\ \(0\)\
\-\ hepatomegaly\\:\\ 0\\.024854974222741407\ \(0\)\
\-\ lytic\\:\\ 0\\.023089049319040815\ \(0\)\
\-\ purulent\\:\\ 0\\.023036120606069146\ \(0\)\
\-\ canals\\:\\ 0\\.02285724027379215\ \(0\)\
\-\ lesion\\:\\ 0\\.021012739146886776\ \(0\)\
\-\ additional\\:\\ 0\\.020682776825855113\ \(0\)\
\-\ abdomen\\:\\ 0\\.020373313987088103\ \(0\)\
\-\ langerhans\\:\\ 0\\.020339309087617448\ \(0\)\
\-\ mastoid\\:\\ 0\\.019813674550727856\ \(0\)\
\-\ sphenoid\\:\\ 0\\.019135112327646194\ \(0\)\
\-\ involving\\:\\ 0\\.018099037810885073\ \(0\)\
\-\ 98\\/59\\:\\ 0\\.017737461617638832\ \(0\)\
\-\ 36\\.8c\\:\\ 0\\.017737461617638832\ \(0\)\
\-\ 105cm\\:\\ 0\\.017737461617638832\ \(0\)\
\-\ 17kg\\:\\ 0\\.017737461617638832\ \(0\)\
\-\ 3\\.5x4cm\\:\\ 0\\.017737461617638832\ \(0\)\
\-\ scabbed\\:\\ 0\\.017737461617638832\ \(0\)\
\-\ 143\\|k\\:\\ 0\\.017737461617638832\ \(0\)\
\-\ 3\\.3\\|cl\\:\\ 0\\.017737461617638832\ \(0\)\
\-\ 109\\|co2\\:\\ 0\\.017737461617638832\ \(0\)\
\-\ 25\\|bun\\:\\ 0\\.017737461617638832\ \(0\)\
\-\ 5\\|cr\\:\\ 0\\.017737461617638832\ \(0\)\
\-\ 0\\.3\\|glu\\:\\ 0\\.017737461617638832\ \(0\)\
\-\ cavarium\\:\\ 0\\.017737461617638832\ \(0\)\
\-\ creams\\:\\ 0\\.017737461617638832\ \(0\)\
\-\ cns\\:\\ 0\\.017597050975759285\ \(0\)\
\-\ erosion\\:\\ 0\\.017367037237972772\ \(0\)\
\-\ diabetes\\:\\ 0\\.017024349880466503\ \(0\)\
\-\ destruction\\:\\ 0\\.01698349526692921\ \(0\)\
\-\ ear\\:\\ 0\\.01694305125947045\ \(0\)\
\-\ urine\\:\\ 0\\.016596259725301227\ \(0\)\
\-\ reassuring\\:\\ 0\\.016342799282508157\ \(0\)\
\-\ pelvises\\:\\ 0\\.016342799282508157\ \(0\)\
\-\ caliectasis\\:\\ 0\\.016342799282508157\ \(0\)\
\-\ griseofulvin\\:\\ 0\\.016342799282508157\ \(0\)\
\-\ \\,\\:\\ 0\\.016340647817944913\ \(0\)\
\-\ occipital\\:\\ 0\\.016045089282350895\ \(0\)\
\-\ polydipsia\\:\\ 0\\.015526974115288509\ \(0\)\
\-\ 286\\:\\ 0\\.014948136947377481\ \(0\)\
\-\ temporalis\\:\\ 0\\.014948136947377481\ \(0\)\
\-\ hydrocortisone\\:\\ 0\\.014948136947377481\ \(0\)\
\-\ parietal\\:\\ 0\\.014691076257718249\ \(0\)\
\-\ bones\\:\\ 0\\.014511196262072748\ \(0\)\
\-\ vinblastine\\:\\ 0\\.014499155958817704\ \(0\)\
\-\ temporoparietal\\:\\ 0\\.014499155958817704\ \(0\)\
\-\ hyperactive\\:\\ 0\\.014132311780157834\ \(0\)\
\-\ non\\-healing\\:\\ 0\\.014132311780157834\ \(0\)\
\-\ cell\\:\\ 0\\.013933042524636736\ \(0\)\
\-\ hematology\\/oncology\\:\\ 0\\.01382214944650138\ \(0\)\
\-\ extrarenal\\:\\ 0\\.01382214944650138\ \(0\)\
\-\ polyuria\\:\\ 0\\.01382214944650138\ \(0\)\
\-\ canal\\:\\ 0\\.013661905129554175\ \(0\)\
\-\ punched\\:\\ 0\\.013553474612246806\ \(0\)\
\-\ left\\:\\ 0\\.013466271398210067\ \(0\)\
\-\ pterygoid\\:\\ 0\\.013316486612938187\ \(0\)\
\-\ cooperative\\:\\ 0\\.013104493623687027\ \(0\)\
\-\ involvement\\:\\ 0\\.012603374875765861\ \(0\)\
\-\ parapharyngeal\\:\\ 0\\.012576597719325878\ \(0\)\
\-\ sinus\\:\\ 0\\.012576092433168765\ \(0\)\
\-\ 2\\-12\\:\\ 0\\.012427487111370704\ \(0\)\
\-\ infundibulum\\:\\ 0\\.012427487111370704\ \(0\)\
\-\ endocrinology\\:\\ 0\\.01228866845646738\ \(0\)\
\-\ into\\:\\ 0\\.012273599806597828\ \(0\)\
\-\ 104\\:\\ 0\\.012158812277116132\ \(0\)\
\-\ langerhan\\:\\ 0\\.01203683114670077\ \(0\)\
\-\ dermatitis\\:\\ 0\\.011921824277807514\ \(0\)\
\-\ 5\\-10\\:\\ 0\\.01181303711227376\ \(0\)\
\-\ resp\\:\\ 0\\.011611661944151056\ \(0\)\
\-\ intra\\-abdominal\\:\\ 0\\.011518060303034573\ \(0\)\
\-\ sodium\\:\\ 0\\.011428620136896075\ \(0\)\
\-\ responsive\\:\\ 0\\.011428620136896075\ \(0\)\
\-\ awake\\:\\ 0\\.011342987109896485\ \(0\)\
\-\ bmp\\:\\ 0\\.011342987109896485\ \(0\)\
\-\ borderline\\:\\ 0\\.011342987109896485\ \(0\)\
\-\ bilaterally\\:\\ 0\\.011294588485005648\ \(0\)\
\-\ otitis\\:\\ 0\\.011260850299996576\ \(0\)\
\-\ obstructed\\:\\ 0\\.011181935384195204\ \(0\)\
\-\ ears\\:\\ 0\\.011105999110587867\ \(0\)\
\-\ tympanic\\:\\ 0\\.011105999110587867\ \(0\)\
\-\ media\\:\\ 0\\.010962218498953772\ \(0\)\
\-\ wing\\:\\ 0\\.010828030622698898\ \(0\)\
\-\ enhancing\\:\\ 0\\.010784521259093599\ \(0\)\
\-\ 1cm\\:\\ 0\\.010702235135814926\ \(0\)\
\-\ mandibular\\:\\ 0\\.010642168811570095\ \(0\)\
\-\ refractory\\:\\ 0\\.010642168811570095\ \(0\)\
\-\ musculature\\:\\ 0\\.010583843787680252\ \(0\)\
\-\ treated\\:\\ 0\\.010293162318244908\ \(0\)\
\-\ prednisone\\:\\ 0\\.010169654543808724\ \(0\)\
\-\ membranes\\:\\ 0\\.01007818095411706\ \(0\)\
\-\ shadow\\:\\ 0\\.00978727304906453\ \(0\)\
\-\ head\\:\\ 0\\.009752922778969402\ \(0\)\
\-\ neurosurgery\\:\\ 0\\.00967441697934412\ \(0\)\
\-\ rhabdomyosarcoma\\:\\ 0\\.00967441697934412\ \(0\)\
\-\ temp\\:\\ 0\\.009533160925675611\ \(0\)\
\-\ na\\:\\ 0\\.00927731550216405\ \(0\)\
\-\ cn\\:\\ 0\\.00924750647643942\ \(0\)\
\-\ managed\\:\\ 0\\.00924750647643942\ \(0\)\
\-\ eosinophilic\\:\\ 0\\.009218132634545753\ \(0\)\
\-\ lesions\\:\\ 0\\.009205474874623533\ \(0\)\
\-\ 41\\:\\ 0\\.00916064093948729\ \(0\)\
\-\ condyle\\:\\ 0\\.00916064093948729\ \(0\)\
\-\ height\\:\\ 0\\.009050362797646254\ \(0\)\
\-\ grossly\\:\\ 0\\.009023712442012409\ \(0\)\
\-\ osteosarcoma\\:\\ 0\\.008945816039234361\ \(0\)\
\-\ pulse\\:\\ 0\\.00887082329316347\ \(0\)\
\-\ neuro\\:\\ 0\\.00887082329316347\ \(0\)\
\-\ nuclear\\:\\ 0\\.00887082329316347\ \(0\)\
\-\ 2\\+\\:\\ 0\\.008798525487879643\ \(0\)\
\-\ antibiotic\\:\\ 0\\.008798525487879643\ \(0\)\
\-\ no\\:\\ 0\\.008656379785752535\ \(0\)\
\-\ consolidation\\:\\ 0\\.008617543120348577\ \(0\)\
\-\ neuroblastoma\\:\\ 0\\.00859602342393661\ \(0\)\
\-\ by\\:\\ 0\\.008588757967272886\ \(0\)\
\-\ alert\\:\\ 0\\.008574731453452632\ \(0\)\
\-\ develop\\:\\ 0\\.008574731453452632\ \(0\)\
\-\ solitary\\:\\ 0\\.008532811761495203\ \(0\)\
\-\ skeletal\\:\\ 0\\.008491747633464605\ \(0\)\
\-\ acute\\:\\ 0\\.008490460076887306\ \(0\)\
\-\ hearing\\:\\ 0\\.008471525629735225\ \(0\)\
\-\ granuloma\\:\\ 0\\.00845150484331034\ \(0\)\
\-\ close\\:\\ 0\\.008392610713933855\ \(0\)\
\-\ soft\\:\\ 0\\.008373950760537426\ \(0\)\
\-\ bilateral\\:\\ 0\\.008345342975108427\ \(0\)\
\-\ distended\\:\\ 0\\.008316674440326516\ \(0\)\
\-\ serum\\:\\ 0\\.008298129862650614\ \(0\)\
\-\ potential\\:\\ 0\\.008279754644213445\ \(0\)\
\-\ chest\\:\\ 0\\.008228285714517178\ \(0\)\
\-\ vitals\\:\\ 0\\.008225614899907762\ \(0\)\
\-\ tissue\\:\\ 0\\.008150588283511444\ \(0\)\
\-\ reflexes\\:\\ 0\\.008138498590544937\ \(0\)\
\-\ 28\\:\\ 0\\.008104681451075358\ \(0\)\
\-\ remainder\\:\\ 0\\.008104681451075358\ \(0\)\
\-\ without\\:\\ 0\\.008096632460193804\ \(0\)\
\-\ 80\\:\\ 0\\.008087983658691665\ \(0\)\
\-\ osteomyelitis\\:\\ 0\\.007990606312893174\ \(0\)\
\-\ kidneys\\:\\ 0\\.007912910465553577\ \(0\)\
\-\ deficits\\:\\ 0\\.007867693451766739\ \(0\)\
\-\ 11\\:\\ 0\\.007867693451766739\ \(0\)\
\-\ l\\:\\ 0\\.007838103617984656\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.007765978604356615\ \(0\)\
\-\ carotid\\:\\ 0\\.007710084109171352\ \(0\)\
\-\ exam\\:\\ 0\\.007554261327764742\ \(0\)\
\-\ clinically\\:\\ 0\\.0075384591986846425\ \(0\)\
\-\ cavity\\:\\ 0\\.007525844283164329\ \(0\)\
\-\ bp\\:\\ 0\\.007463929476993799\ \(0\)\
\-\ near\\:\\ 0\\.0074396873471825825\ \(0\)\
\-\ skull\\:\\ 0\\.007322673423325291\ \(0\)\
\-\ intracranial\\:\\ 0\\.007266623213057753\ \(0\)\
\-\ general\\:\\ 0\\.00724463313150405\ \(0\)\
\-\ distress\\:\\ 0\\.00724463313150405\ \(0\)\
\-\ us\\:\\ 0\\.007212092167227187\ \(0\)\
\-\ drainage\\:\\ 0\\.007190686939450415\ \(0\)\
\-\ hepatic\\:\\ 0\\.007180069118321956\ \(0\)\
\-\ mass\\:\\ 0\\.007173808895055721\ \(0\)\
\-\ prominent\\:\\ 0\\.007056842508179665\ \(0\)\
\-\ 12\\:\\ 0\\.007037018974089098\ \(0\)\
\-\ range\\:\\ 0\\.006922012105195842\ \(0\)\
\-\ narrowing\\:\\ 0\\.006894258941951705\ \(0\)\
\-\ bony\\:\\ 0\\.006875967248387818\ \(0\)\
\-\ extensive\\:\\ 0\\.006875967248387818\ \(0\)\
\-\ sounds\\:\\ 0\\.006857840347095331\ \(0\)\
\-\ complications\\:\\ 0\\.006813224939662087\ \(0\)\
\-\ rate\\:\\ 0\\.006701652898341738\ \(0\)\
\-\ second\\:\\ 0\\.0066038811574224915\ \(0\)\
\-\ greater\\:\\ 0\\.006458181806178071\ \(0\)\
\-\ throughout\\:\\ 0\\.006436111320522991\ \(0\)\
\-\ \\‚\\Ä\\ú\\:\\ 0\\.006421531021688451\ \(0\)\
\-\ \\‚\\Ä\\ù\\:\\ 0\\.006385535921586288\ \(0\)\
\-\ abnormality\\:\\ 0\\.006343174937284814\ \(0\)\
\-\ intact\\:\\ 0\\.006315421774040678\ \(0\)\
\-\ abnormalities\\:\\ 0\\.006315421774040678\ \(0\)\
\-\ middle\\:\\ 0\\.006288046216584383\ \(0\)\
\-\ pelvis\\:\\ 0\\.006247668826140099\ \(0\)\
\-\ risk\\:\\ 0\\.006227779974565567\ \(0\)\
\-\ otherwise\\:\\ 0\\.006175684574298481\ \(0\)\
\-\ weight\\:\\ 0\\.006162868782979608\ \(0\)\
\-\ identified\\:\\ 0\\.006143796863553967\ \(0\)\
\-\ typically\\:\\ 0\\.006069267141863123\ \(0\)\
\-\ location\\:\\ 0\\.005997399772442441\ \(0\)\
\-\ given\\:\\ 0\\.005894193948725036\ \(0\)\
\-\ for\\:\\ 0\\.005868073630927285\ \(0\)\
\-\ inferior\\:\\ 0\\.005833634529897511\ \(0\)\
\-\ this\\:\\ 0\\.005801633078354927\ \(0\)\
\-\ followed\\:\\ 0\\.005764337769373786\ \(0\)\
\-\ internal\\:\\ 0\\.005764337769373786\ \(0\)\
\-\ out\\:\\ 0\\.005682200959473876\ \(0\)\
\-\ along\\:\\ 0\\.005682200959473876\ \(0\)\
\-\ study\\:\\ 0\\.005657205949416417\ \(0\)\
\-\ surrounding\\:\\ 0\\.005652243992685645\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.005593635797669501\ \(0\)\
\-\ mr\\:\\ 0\\.005463178011964657\ \(0\)\
\-\ right\\:\\ 0\\.005442444924207746\ \(0\)\
\-\ frontal\\:\\ 0\\.0054009898078135965\ \(0\)\
\-\ bowel\\:\\ 0\\.0053922606295467995\ \(0\)\
\-\ normal\\:\\ 0\\.005390794585911876\ \(0\)\
\-\ approximately\\:\\ 0\\.005319552970936787\ \(0\)\
\-\ age\\:\\ 0\\.005233219970914098\ \(0\)\
\-\ fat\\:\\ 0\\.005229199844832261\ \(0\)\
\-\ diffuse\\:\\ 0\\.005205246318662606\ \(0\)\
\-\ brain\\:\\ 0\\.005173745519723868\ \(0\)\
\-\ patient\\:\\ 0\\.005170575035712603\ \(0\)\
\-\ to\\:\\ 0\\.005155751812188969\ \(0\)\
\-\ \\‚\\Ä\\ô\\:\\ 0\\.005138886800091461\ \(0\)\
\-\ artery\\:\\ 0\\.0051197786561533185\ \(0\)\
\-\ in\\:\\ 0\\.005087290504711327\ \(0\)\
\-\ neck\\:\\ 0\\.0050487789477233055\ \(0\)\
\-\ years\\:\\ 0\\.0050487789477233055\ \(0\)\
\-\ demonstrated\\:\\ 0\\.005045110628686051\ \(0\)\
\-\ pulmonary\\:\\ 0\\.005023240060804957\ \(0\)\
\-\ loss\\:\\ 0\\.004990873586455613\ \(0\)\
\-\ wall\\:\\ 0\\.004980199437100093\ \(0\)\
\-\ not\\:\\ 0\\.004969089222301552\ \(0\)\
\-\ s\\:\\ 0\\.0049311220666289485\ \(0\)\
\-\ changes\\:\\ 0\\.004927661924014207\ \(0\)\
\-\ appearance\\:\\ 0\\.004917317055804108\ \(0\)\
\-\ focal\\:\\ 0\\.004910449907723143\ \(0\)\
\-\ fluid\\:\\ 0\\.004886597795983608\ \(0\)\
\-\ scan\\:\\ 0\\.004813423461635772\ \(0\)\
\-\ ct\\:\\ 0\\.004810075063951883\ \(0\)\
\-\ secondary\\:\\ 0\\.004806901341064\ \(0\)\
\-\ 4\\:\\ 0\\.004790687937986007\ \(0\)\
\-\ history\\:\\ 0\\.0047493542764872575\ \(0\)\
\-\ months\\:\\ 0\\.004696058943038365\ \(0\)\
\-\ significant\\:\\ 0\\.004623434911577915\ \(0\)\
\-\ due\\:\\ 0\\.0045880828027220115\ \(0\)\
\-\ anterior\\:\\ 0\\.004428154574975327\ \(0\)\
\-\ \\(\\:\\ 0\\.004360332351572599\ \(0\)\
\-\ and\\:\\ 0\\.004346293900979117\ \(0\)\
\-\ \\)\\:\\ 0\\.004307068564064215\ \(0\)\
\-\ physical\\:\\ 0\\.0042183204619340815\ \(0\)\
\-\ increased\\:\\ 0\\.004206206804425867\ \(0\)\
\-\ upper\\:\\ 0\\.004149055342794202\ \(0\)\
\-\ associated\\:\\ 0\\.004057268736232801\ \(0\)\
\-\ tumor\\:\\ 0\\.004008515697406059\ \(0\)\
\-\ were\\:\\ 0\\.003903996653299641\ \(0\)\
\-\ present\\:\\ 0\\.0038833174123373863\ \(0\)\
\-\ case\\:\\ 0\\.003761578335749036\ \(0\)\
\-\ large\\:\\ 0\\.003759642719982052\ \(0\)\
\-\ lateral\\:\\ 0\\.0037156298704719326\ \(0\)\
\-\ but\\:\\ 0\\.0036670086539910217\ \(0\)\
\-\ old\\:\\ 0\\.0035208635688621917\ \(0\)\
\-\ treatment\\:\\ 0\\.0034801146068428315\ \(0\)\
\-\ male\\:\\ 0\\.0031090654685864655\ \(0\)\
\-\ on\\:\\ 0\\.002913042303281401\ \(0\)\
\-\ with\\:\\ 0\\.0028250505293333536\ \(0\)\
\-\ disease\\:\\ 0\\.002810337105061779\ \(0\)\
\-\ the\\:\\ 0\\.002781675748563899\ \(0\)\
\-\ there\\:\\ 0\\.002558783815824927\ \(0\)\
\-\ from\\:\\ 0\\.0025481603886402665\ \(0\)\
\-\ at\\:\\ 0\\.002329503325616968\ \(0\)\
\-\ is\\:\\ 0\\.0022627395508439665\ \(0\)\
\-\ or\\:\\ 0\\.0020151363158223494\ \(0\)\
\-\ was\\:\\ 0\\.001988485960188505\ \(0\)\
\-\ year\\:\\ 0\\.0019237530568871526\ \(0\)\
\-\ of\\:\\ 0\\.0018753126889012224\ \(0\)\
\-\ \\.\\:\\ 0\\.0015714080365022496\ \(0\)\
